Evgen Pharma
About:
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions
Website: http://evgen.com/
Twitter/X: evgenpharma
Top Investors: Seneca Partners, The North West Fund, Acceleris Capital, Enterprise Ventures, Sarum Partners
Description:
Evgen Pharma is a clinical stage drug development company focused on the treatment of cancer and neurological conditions. Evgen’s pipeline is based on our proprietary Sulforadex® technology, and includes a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to use our Sulforadex® technology to turn this scientific promise into commercially successful products.
$16.4M
$1M to $10M
Wilmslow, Cheshire, United Kingdom
2007-01-01
enquiries(AT)evgen.com
Stephen Franklin
1-10
2021-02-03
Public
© 2025 bioDAO.ai